These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34216521)

  • 1. Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with amyotrophic lateral sclerosis.
    Holdom CJ; Janse van Mantgem MR; van Eijk RPA; Howe SL; van den Berg LH; McCombe PA; Henderson RD; Ngo ST; Steyn FJ
    Eur J Neurol; 2021 Nov; 28(11):3615-3625. PubMed ID: 34216521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.
    Lee I; Kazamel M; McPherson T; McAdam J; Bamman M; Amara A; Smith DL; King PH
    PLoS One; 2021; 16(5):e0251087. PubMed ID: 33956876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
    Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G;
    JAMA Neurol; 2014 Sep; 71(9):1134-42. PubMed ID: 25048026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.
    Shepheard SR; Karnaros V; Benyamin B; Schultz DW; Dubowsky M; Wuu J; Chataway T; Malaspina A; Benatar M; Rogers ML
    Eur J Neurol; 2022 Apr; 29(4):990-999. PubMed ID: 34967083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis.
    Lanznaster D; Bejan-Angoulvant T; Patin F; Andres CR; Vourc'h P; Corcia P; Blasco H
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):199-206. PubMed ID: 30961401
    [No Abstract]   [Full Text] [Related]  

  • 7. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.
    Chang J; Shaw TB; Holdom CJ; McCombe PA; Henderson RD; Fripp J; Barth M; Guo CC; Ngo ST; Steyn FJ;
    Eur J Neurol; 2023 Jan; 30(1):57-68. PubMed ID: 36214080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood biomarkers and prognosis of amyotrophic lateral sclerosis.
    Sun J; Carrero JJ; Zagai U; Evans M; Ingre C; Pawitan Y; Fang F
    Eur J Neurol; 2020 Nov; 27(11):2125-2133. PubMed ID: 32557963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis.
    Rafiq MK; Lee E; Bradburn M; McDermott CJ; Shaw PJ
    Eur J Neurol; 2016 Jun; 23(6):1071-8. PubMed ID: 27029589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis.
    Guo QF; Hu W; Xu LQ; Luo H; Wang N; Zhang QJ
    Ann Clin Transl Neurol; 2021 Feb; 8(2):448-455. PubMed ID: 33449454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients.
    Marin B; Desport JC; Kajeu P; Jesus P; Nicolaud B; Nicol M; Preux PM; Couratier P
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):628-34. PubMed ID: 21097551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis.
    Li JY; Cui LY; Sun XH; Shen DC; Yang XZ; Liu Q; Liu MS
    Ann Clin Transl Neurol; 2022 Jul; 9(7):1027-1038. PubMed ID: 35584112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.
    van Eijk RPA; Eijkemans MJC; Ferguson TA; Nikolakopoulos S; Veldink JH; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):156-161. PubMed ID: 29084868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis.
    Howe SL; Holdom CJ; McCombe PA; Henderson RD; Zigman JM; Ngo ST; Steyn FJ
    Eur J Neurol; 2024 Jan; 31(1):e16052. PubMed ID: 37658515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis.
    Li JY; Sun XH; Cai ZY; Shen DC; Yang XZ; Liu MS; Cui LY
    Sci Rep; 2022 Aug; 12(1):13292. PubMed ID: 35918363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis.
    Yamada S; Hashizume A; Hijikata Y; Ito D; Kishimoto Y; Iida M; Koike H; Hirakawa A; Katsuno M
    J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1072-1079. PubMed ID: 33737450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary p75
    Shepheard SR; Wuu J; Cardoso M; Wiklendt L; Dinning PG; Chataway T; Schultz D; Benatar M; Rogers ML
    Neurology; 2017 Mar; 88(12):1137-1143. PubMed ID: 28228570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Liu J; Luo X; Chen X; Shang H
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(7-8):502-508. PubMed ID: 32564621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low plasma hyaluronan is associated with faster functional decline in patients with amyotrophic lateral sclerosis.
    Holdom CJ; Ngo ST; McCombe PA; Henderson RD; Steyn FJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Feb; 23(1-2):42-48. PubMed ID: 34569358
    [No Abstract]   [Full Text] [Related]  

  • 20. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.
    Peter RS; Rosenbohm A; Dupuis L; Brehme T; Kassubek J; Rothenbacher D; Nagel G; Ludolph AC
    Eur J Epidemiol; 2017 Oct; 32(10):901-908. PubMed ID: 28975435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.